Abstract
BackgroundThe result of post-marketing surveillance (PMS) of 3985 patients reported previously1 indicated that prior use of biologics, with or without concomitant methotrexate (MTX), was associated with the safety and effectiveness...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have